Sun Pharmaceutical Industries and Strides Arcolab have entered into a definitive agreement to acquire erstwhile Ranbaxy’s Solus and Solus Care for Rs 165 crore.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Sun Pharmaceutical Industries and Strides Arcolab have entered into a definitive agreement to acquire erstwhile Ranbaxy’s Solus and Solus Care for Rs 165 crore.
| Subscribe To Our Free Newsletter |
